NCT05244460View on ClinicalTrials.gov

Droperidol on Prevention of Cannabis Hyperemesis Syndrome

PHASE3UnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Cannabis Hyperemesis Syndrome
Interventions
DRUG

Droperidol Injectable Product

Treatment

DRUG

Diphenhydramine

Treatment

Trial Locations (4)

44484

RECRUITING

St. Joseph-Warren Hospital, Warren

44501

RECRUITING

St Elizabeth Youngstown Hospital, Youngstown

44512

RECRUITING

St Elizabeth Boardman Hospital, Boardman

44515

RECRUITING

Mercy Health - Austintown, Austintown

Sponsors

Lead Sponsor

Mercy Health Ohio
All Listed Sponsors
collaborator

Lake Erie College of Osteopathic Medicine

OTHER

lead

Mercy Health Ohio

OTHER